6fzq
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Crystal structure of scFv-SM3 in complex with compound 3== | ==Crystal structure of scFv-SM3 in complex with compound 3== | ||
| - | <StructureSection load='6fzq' size='340' side='right' caption='[[6fzq]], [[Resolution|resolution]] 1.70Å' scene=''> | + | <StructureSection load='6fzq' size='340' side='right'caption='[[6fzq]], [[Resolution|resolution]] 1.70Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[6fzq]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6FZQ OCA]. For a <b>guided tour on the structure components</b> use [ | + | <table><tr><td colspan='2'>[[6fzq]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6FZQ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6FZQ FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=EEN:N- | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.7Å</td></tr> |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=EEN:2,2-bis(fluoranyl)-~{N}-[(2~{S},3~{R},4~{R},5~{R},6~{R})-6-(hydroxymethyl)-2,4,5-tris(oxidanyl)oxan-3-yl]ethanamide'>EEN</scene></td></tr> |
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6fzq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6fzq OCA], [https://pdbe.org/6fzq PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6fzq RCSB], [https://www.ebi.ac.uk/pdbsum/6fzq PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6fzq ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| - | == | + | <div style="background-color:#fffaf0;"> |
| - | + | == Publication Abstract from PubMed == | |
| - | + | The tumor-associated carbohydrate Tn antigens include two variants, alphaGalNAc- O-Thr and alphaGalNAc- O-Ser. In solution, they exhibit dissimilar shapes and dynamics and bind differently to the same protein receptor. Here, we demonstrate experimentally and theoretically that their conformational preferences in the gas phase are highly similar, revealing the essential role of water. We propose that water molecules prompt the rotation around the glycosidic linkage in the threonine derivative, shielding its hydrophobic methyl group and allowing an optimal solvation of the polar region of the antigen. The unusual arrangement of alphaGalNAc- O-Thr features a water molecule bound into a "pocket" between the sugar and the threonine. This mechanism is supported by trapping, for the first time, such localized water in the crystal structures of an antibody bound to two glycopeptides that comprise fluorinated Tn antigens in their structure. According to several reported X-ray structures, installing oxygenated amino acids in specific regions of the receptor capable of displacing the bridging water molecule to the bulk-solvent may facilitate the molecular recognition of the Tn antigen with threonine. Overall, our data also explain how water fine-tunes the 3D structure features of similar molecules, which in turn are behind their distinct biological activities. | |
| - | + | ||
| + | Water Sculpts the Distinctive Shapes and Dynamics of the Tumor-Associated Carbohydrate Tn Antigens: Implications for Their Molecular Recognition.,Bermejo IA, Usabiaga I, Companon I, Castro-Lopez J, Insausti A, Fernandez JA, Avenoza A, Busto JH, Jimenez-Barbero J, Asensio JL, Peregrina JM, Jimenez-Oses G, Hurtado-Guerrero R, Cocinero EJ, Corzana F J Am Chem Soc. 2018 Aug 8;140(31):9952-9960. doi: 10.1021/jacs.8b04801. Epub 2018 , Jul 30. PMID:30004703<ref>PMID:30004703</ref> | ||
| + | |||
| + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
| + | </div> | ||
| + | <div class="pdbe-citations 6fzq" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Antibody 3D structures|Antibody 3D structures]] | ||
| + | *[[Monoclonal Antibodies 3D structures|Monoclonal Antibodies 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: Asensio | + | [[Category: Homo sapiens]] |
| - | [[Category: Avenoza | + | [[Category: Large Structures]] |
| - | [[Category: Bermejo | + | [[Category: Mus musculus]] |
| - | [[Category: Busto | + | [[Category: Asensio JL]] |
| - | [[Category: Castro-Lopez | + | [[Category: Avenoza A]] |
| - | [[Category: Cocinero | + | [[Category: Bermejo IA]] |
| - | [[Category: Companon | + | [[Category: Busto JH]] |
| - | [[Category: Corzana | + | [[Category: Castro-Lopez J]] |
| - | [[Category: Fernandez | + | [[Category: Cocinero EJ]] |
| - | [[Category: Hurtado-Guerrero | + | [[Category: Companon I]] |
| - | [[Category: Insausti | + | [[Category: Corzana F]] |
| - | [[Category: Jimenez-Barbero | + | [[Category: Fernandez JA]] |
| - | [[Category: Jimenez-Oses | + | [[Category: Hurtado-Guerrero R]] |
| - | [[Category: Peregrina | + | [[Category: Insausti A]] |
| - | [[Category: Usabiaga | + | [[Category: Jimenez-Barbero J]] |
| - | + | [[Category: Jimenez-Oses G]] | |
| + | [[Category: Peregrina JM]] | ||
| + | [[Category: Usabiaga I]] | ||
Current revision
Crystal structure of scFv-SM3 in complex with compound 3
| |||||||||||
